phenylacetic acid has been researched along with Kahler Disease in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goals of this study were to determine whether PA and PB (a) are cytotoxic to malignant B cells from patients with non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia and (b) exhibit additive or synergistic induction of apoptosis when administered to myeloma cell lines in combination with conventional drugs." | 1.31 | Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents. ( Kaufmann, SH; Stenson, M; Svingen, PA; Timm, M; Witzig, TE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Witzig, TE | 1 |
| Timm, M | 1 |
| Stenson, M | 1 |
| Svingen, PA | 1 |
| Kaufmann, SH | 1 |
1 other study available for phenylacetic acid and Kahler Disease
| Article | Year |
|---|---|
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; Drug Interactions; Drug Synergism; H | 2000 |